cbdMD Free Cash Flow (FCF) History (YCBD)
cbdMD reported −$1.6M in free cash flow for fiscal 2025, a decrease of $1.1M from the previous fiscal year, with a free cash flow margin of −8.53%.
View full cbdMD company overviewcbdMD free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-09-30 | −$1.6M | −$1.1M | — | −8.53% |
| 2024 | 2024-09-30 | −$542,807 | $4.1M | — | −2.72% |
| 2023 | 2023-09-30 | −$4.6M | $11.1M | — | −18.36% |
| 2022 | 2022-09-30 | −$15.7M | −$1.2M | — | −42.17% |
| 2021 | 2021-09-30 | −$14.4M | −$2.5M | — | −30.50% |
| 2020 | 2020-09-30 | −$12.0M | $4.6M | — | −28.61% |
| 2019 | 2019-09-30 | −$16.6M | −$11.0M | — | −70.08% |
| 2018 | 2018-09-30 | −$5.6M | −$3.3M | — | −1219.07% |
| 2017 | 2017-09-30 | −$2.3M | $686,705 | — | −52.24% |
| 2016 | 2016-09-30 | −$3.0M | — | — | −148.88% |
cbdMD quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | −$460,223 | $245,452 | — | −8.29% |
| Q2 2026 | 2026-03-31 | −$728,248 | −$523,265 | — | −12.91% |
| Q1 2026 | 2025-12-31 | −$977,266 | −$494,930 | — | −19.48% |
| Q4 2025 | 2025-09-30 | −$243,553 | −$400,930 | — | −5.16% |
| Q3 2025 | 2025-06-30 | −$705,675 | −$995,454 | — | −15.32% |
| Q2 2025 | 2025-03-31 | −$204,983 | $503,705 | — | −4.32% |
| Q1 2025 | 2024-12-31 | −$482,336 | −$191,821 | — | −9.43% |
| Q4 2024 | 2024-09-30 | $157,377 | $541,058 | — | +3.45% |
| Q3 2024 | 2024-06-30 | $289,779 | $632,741 | — | +5.60% |
| Q2 2024 | 2024-03-31 | −$708,688 | $1.1M | — | −14.71% |
| Q1 2024 | 2023-12-31 | −$290,515 | $2.0M | — | −5.40% |
| Q4 2023 | 2023-09-30 | −$383,681 | $1.8M | — | −6.65% |
| Q3 2023 | 2023-06-30 | −$342,962 | $2.1M | — | −5.31% |
| Q2 2023 | 2023-03-31 | −$1.8M | $3.5M | — | −27.88% |
| Q1 2023 | 2022-12-31 | −$2.2M | $3.5M | — | −35.92% |
| Q4 2022 | 2022-09-30 | −$2.2M | $2.2M | — | −25.47% |
| Q3 2022 | 2022-06-30 | −$2.5M | $2.2M | — | −27.73% |
| Q2 2022 | 2022-03-31 | −$5.3M | −$2.3M | — | −53.72% |
| Q1 2022 | 2021-12-31 | −$5.7M | −$3.4M | — | −57.82% |
| Q4 2021 | 2021-09-30 | −$4.4M | −$3.4M | — | −36.82% |
| Q3 2021 | 2021-06-30 | −$4.7M | −$3.5M | — | −41.34% |
| Q2 2021 | 2021-03-31 | −$3.1M | $2.4M | — | −26.21% |
| Q1 2021 | 2020-12-31 | −$2.3M | $3.1M | — | −18.54% |
| Q4 2020 | 2020-09-30 | −$918,905 | $6.2M | — | −7.85% |
| Q3 2020 | 2020-06-30 | −$1.2M | $3.7M | — | −11.14% |
| Q2 2020 | 2020-03-31 | −$5.5M | −$2.1M | — | −58.67% |
| Q1 2020 | 2019-12-31 | −$5.4M | −$4.3M | — | −53.50% |
| Q4 2019 | 2019-09-30 | −$7.2M | −$6.4M | — | −75.03% |
| Q3 2019 | 2019-06-30 | −$4.9M | −$3.6M | — | −60.59% |
| Q2 2019 | 2019-03-31 | −$3.4M | −$1.7M | — | −60.17% |
| Q1 2019 | 2018-12-31 | −$1.2M | $650,757 | — | −251.85% |
| Q4 2018 | 2018-09-30 | −$753,821 | $165,719 | — | — |
| Q3 2018 | 2018-06-30 | −$1.3M | −$1.2M | — | −40.26% |
| Q2 2018 | 2018-03-31 | −$1.7M | −$969,097 | — | −56.22% |
| Q1 2018 | 2017-12-31 | −$1.8M | −$1.3M | — | −265.15% |
| Q4 2017 | 2017-09-30 | −$919,540 | — | — | −85.18% |
| Q3 2017 | 2017-06-30 | −$133,684 | — | — | −7.48% |
| Q2 2017 | 2017-03-31 | −$763,015 | — | — | −54.17% |
| Q1 2017 | 2016-12-31 | −$535,671 | — | — | −268.05% |
cbdMD free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$12.0M to −$1.6M, a net increase of $10.3M. cbdMD's latest reported quarter, Q3 2026, generated −$460,223 in free cash flow, an increase of $245,452 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review cbdMD filings at SEC.gov ↗